Cargando…
Current and emerging adjuvant therapies in biliary atresia
Following Kasai hepatic portoenterostomy (HPE), most patients with biliary atresia will eventually require liver transplantation due to progressive cirrhosis and liver failure. Preventing liver transplantation, or even delaying eventual liver transplantation, is the key to improving long-term outcom...
Autores principales: | Fligor, Scott C., Hirsch, Thomas I., Tsikis, Savas T., Adeola, Andrew, Puder, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614654/ https://www.ncbi.nlm.nih.gov/pubmed/36313875 http://dx.doi.org/10.3389/fped.2022.1007813 |
Ejemplares similares
-
Targeting the lung endothelial niche to promote angiogenesis and regeneration: A review of applications
por: Tsikis, Savas T., et al.
Publicado: (2022) -
Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease
por: Secor, Jordan D., et al.
Publicado: (2021) -
Editorial: Elimination of biliary atresia
por: Kotb, Magd Ahmed, et al.
Publicado: (2023) -
Adjuvant treatments for biliary atresia
por: Burns, Jessica, et al.
Publicado: (2020) -
Meconium Peritonitis, Intestinal Atresia Combined With Biliary Atresia: A Case Report
por: Han, Yijiang, et al.
Publicado: (2022)